MRNX Performance — Defiance Daily Target 2X Long MRNA ETF
Data updated: 2026-09-28
In the 12 months to Jul 2026 the fund took in a net $2.2M, and assets reached $2.18M.
MRNX Growth of $100
What $100 invested in Defiance Daily Target 2X Long MRNA ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | MRNX | Category average |
|---|---|---|
| Since data start (Feb 2026 – Jul 2026) | $121 | $98 |
MRNX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +21.38% |
MRNX Annual Returns
Calendar-year total returns of Defiance Daily Target 2X Long MRNA ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Feb–Jul) | +21.38% |
MRNX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | — | +56.0% | −15.8% | −20.8% | +0.9% | +103.5% | −43.2% | — | — | — | — | — |
MRNX Risk
Risk measures from monthly returns over Feb 2026 – Jul 2026.
- Best month: +103.51% (Jun 2026)
- Worst month: −43.18% (Jul 2026)
MRNX Fund Flows
Monthly money in and out of Defiance Daily Target 2X Long MRNA ETF, from SEC Form N-PORT.
- 12-month net flow: $2.2M
- 12-month gross sales (incl. reinvestments): $6.9M
- Sales ÷ redemptions: 1.45×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $1.6M | $1.8M | −$143K |
| Jun 2026 | $423K | $685K | −$262K |
| May 2026 | $2.8M | $495K | $2.3M |
| Apr 2026 | $294K | $878K | −$584K |
| Mar 2026 | $354K | $0 | $354K |
| Feb 2026 | $1.4M | $920K | $451K |
MRNX Assets Under Management
Net assets of Defiance Daily Target 2X Long MRNA ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $2.18M |
| 2026-04-30 | $415.99K |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.